4.4 Review

CRISPR Systems Suitable for Single AAV Vector Delivery

期刊

CURRENT GENE THERAPY
卷 22, 期 1, 页码 1-14

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1566523221666211006120355

关键词

CRISPR; CRISPR; Cas9; gene therapy; Cas9; orthologs; AAV

资金

  1. Howard Hughes Medical Institute
  2. Foundation Fighting Blindness - NIHR Oxford Biomedical Research Centre
  3. Retina UK

向作者/读者索取更多资源

CRISPR/Cas gene editing is a revolutionary technology for correcting genetic mutations in vivo. AAV vectors are potential tools for delivering CRISPR/Cas, but their limited capacity is a restriction. Identifying smaller Cas orthologs that can be packaged into a single AAV would optimize gene editing and expand the targeted genetic sites.
CRISPR (clustered regularly interspaced short palindromic repeats)/Cas gene editing is a revolutionary technology that can enable the correction of genetic mutations in vivo, providing great promise as a therapeutic intervention for inherited diseases. Adeno-associated viral (AAV) vectors are a potential vehicle for delivering CRISPR/Cas. However, they are restricted by their limited packaging capacity. Identifying smaller Cas orthologs that can be packaged, along with the required guide RNA elements, into a single AAV would be an important optimization for CRISPR/Cas gene editing. Expanding the options of Cas proteins that can be delivered by a single AAV not only increases translational application but also expands the genetic sites that can be targeted for editing. This review considers the benefits and current scope of small Cas protein orthologs that are suitable for gene editing approaches using single AAV vector delivery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据